News Releases

SonoMotion announces FDA 510(k) clearance for the next generation Break Wave device featuring therapy probes with 31% smaller footprint, lighter weight and easier handling.

Break Wave lithotripsy device meets pivotal trial primary endpoints.  Full trial results to be presented in a plenary session at the American Urological Association annual meeting on May 16, 2026 at 11am ET.

Come visit the SonoMotion booth at the American Urological Association conference in Washington DC on May 15-17, 2026 (Booth #1508)

Come visit the SonoMotion booth at the American Urological Association conference in Las Vegas, NV on April 26-28, 2025 (Booth #1807)